Consumer nutrition platform HealthKart has raised $135 million in a funding round led by Temasek with participation from A91 Partners and Kae Capital.
This is particularly relevant for older adults who often juggle multiple health issues and may feel foggy or fatigued due to
How To Buy Xanax Online their prescriptions. Community resources,
Real Zolpidem online such as
Ultram Safe support groups and educational workshops, can further enhance this understanding. The
Order Ambien Online future of withdrawal management lies in a nuanced approach that considers the individual’s unique context, including their medical history, mental health status, and
Ambien Legally social environment. healthcare
Tramadol Next Day Delivery Buy Xanax Without Rx system. The exacerbation of stressors such as
Trusted site to Buy Ambien job loss, financial instability, and limited access
Carisoprodol No Rx to healthcare services has contributed to a decline in overall well-being. Individuals might experience
Klonopin Online mood swings, anxiety, depression, and
Xanax Overnight difficulty in cognitive functions. For instance,
Trusted site to Buy Klonopin they may notice that certain activities or even emotional
Soma Overnight states have a significant impact on their pain levels. In several US studies over the past decade, researchers have made significant strides in understanding respiratory depression,
Ativan Buy Online Valium 10Mg Buy Online particularly its prevalence among patients receiving opioid therapy for pain management. This symptom can arise from a variety of
Xanax Cheap Xanax Cheap causes, and in the context of spasmolytic medications, it is often related to how these drugs interact with the nervous system.
The fresh capital will be deployed towards the growth of in-house D2C brands, increase offline distribution, expand international operations, and make select acquisitions, the company said in a press release.
While the company did not disclose its valuation, it was valued at around Rs 3,150 crore or $390 million during the first tranche of this round. Entrackr had exclusively reported the development.
Healthkart owns and manufactures eight nutritional brands including popular supplement brands like MuscleBlaze, The Protein Zone, TrueBasics, HKVitals, bGreen, Nouriza, and Gritzo. Besides its own platform, the company sells its product through D2C websites, offline grocers, chemists, e-commerce and quick commerce platforms, and more than 140 HealthKart offline stores.
According to the company, MuscleBlaze has grown rapidly over the last few years, and now has a 25% share of India’s sports nutrition market whereas HKVitals has ~20% share of the online health supplement market.
HealthKart’s operating revenue remained somewhat stable at Rs 310 crore in FY21 as compared to Rs 335 crore in FY20. The firm claims that it clocked Rs 700 crore in revenue for FY22.
Prior to this round, HealthKart raised $25 million in a Series G round led by Belgian private equity firm Sofina Group in May 2019. It has raised nearly $200 million to date.
Source @Entrackr
